Internal Medicine, Endocrinology, Diabetes, & Metabolism · Philadelphia, PA
NPI
1003525429
Since 2022
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3401 N Broad St
Philadelphia, PA, 19140
Phone (215) 707-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
207 services
Medicare patients, 2024
134
Average age 69
Drug cost, 2024
$2.9M
5,723 prescriptions
Company payments, 2024
$21.23
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherry Brooks was code 99214 (office e&m - established), 188 times for 121 patients. In total Sherry Brooks billed 207 services in 2 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 188 | 121 | $61.92 | $12K |
| 99204 Office E&M - New | Facility | 18 | 18 | $76.77 | $1,382 |
By year: 2023 $5,428 for 74 services; 2024 $13K for 207 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sherry Brooks prescribed most often to Medicare patients was Trulicity (Dulaglutide), with 604 prescriptions and refills. In total Sherry Brooks wrote 5,723 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | 604 | 700 | 129 | $660K |
| Metformin Hcl Generic | 539 | 1,118 | 161 | $6,500 |
| Ozempic Semaglutide | 518 | 655 | 117 | $607K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 487 | 1,141 | 175 | $63K |
| Jardiance Empagliflozin | 456 | 798 | 113 | $448K |
| Farxiga Dapagliflozin Propanediol | 271 | 413 | 74 | $224K |
| Metformin Hcl Er Metformin Hcl | 228 | 558 | 81 | $5,164 |
| Novolog Flexpen Insulin Aspart | 193 | 337 | 62 | $41K |
| Humalog Kwikpen U-100 Insulin Lispro | 173 | 293 | 48 | $39K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 172 | 324 | 60 | $43K |
| Mounjaro Tirzepatide | 164 | 193 | 35 | $199K |
| Baqsimi Glucagon | 98 | 98 | 47 | $29K |
| Pioglitazone Hcl Generic | 95 | 165 | 22 | $1,537 |
| Gvoke Hypopen 2-Pack Glucagon | 92 | 92 | 65 | $52K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 91 | 220 | 36 | $37K |
Brand drugs: 4,033 claims; generic drugs: 1,192 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Sherry Brooks $21.23 ($21.23 in general payments such as food, travel and fees) from 1 company. The largest payer was Insulet Corporation with $21.23.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 1 | $21.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.